<?xml version="1.0"?>
<case>
<name>Bodum v Housewares International Limited [2007] FCA 44 (6 February 2007)</name>
<AustLII>http://www.austlii.edu.au/au/cases/cth/FCA/2007/44.html</AustLII>
<citphrases>
<citphrase id="cp0.0" type=cited from="[2005] FCAFC 246">designs</citphrase>
<citphrase id="cp0.1" type=cited from="[2005] FCAFC 246">appellant and respondent competitors in market for locking systems</citphrase>
<citphrase id="cp0.2" type=cited from="[2005] FCAFC 246">claim that respondent's registered designs invalid</citphrase>
<citphrase id="cp0.3" type=cited from="[2005] FCAFC 246">registration of designs a consideration for consumers in the market</citphrase>
<citphrase id="cp0.4" type=cited from="[2005] FCAFC 246">whether appellant a "person aggrieved" or a "person interested"</citphrase>
<citphrase id="cp2.0" type=cited from="[1998] FCA 699">negligence</citphrase>
<citphrase id="cp2.1" type=cited from="[1998] FCA 699">medical negligence</citphrase>
<citphrase id="cp2.2" type=cited from="[1998] FCA 699">asthmatic child suffers brain damage after use of suppository prescribed by general practitioner</citphrase>
<citphrase id="cp2.3" type=cited from="[1998] FCA 699">whether theophylline contained in suppository caused brain damage</citphrase>
<citphrase id="cp2.4" type=cited from="[1998] FCA 699">whether trial judge entitled to reject strong views of paediatric pharmacologist based on reports of limited laboratory tests performed on other children</citphrase>
<citphrase id="cp2.5" type=cited from="[1998] FCA 699">whether trial judge entitled to prefer contrary medical evidence based on clinical experience and reading of medical literature</citphrase>
<citphrase id="cp2.6" type=cited from="[1998] FCA 699">advantage of trial judge in assessing witnesses</citphrase>
<citphrase id="cp2.7" type=cited from="[1998] FCA 699">appeal court should acknowledge such advantage</citphrase>
<citphrase id="cp2.8" type=cited from="[1998] FCA 699">question of fact</citphrase>
<citphrase id="cp2.9" type=cited from="[1998] FCA 699">no error shown. negligence</citphrase>
<citphrase id="cp2.10" type=cited from="[1998] FCA 699">medical negligence</citphrase>
<citphrase id="cp2.11" type=cited from="[1998] FCA 699">conflicting evidence as to practice by general medical practitioners at relevant time</citphrase>
<citphrase id="cp2.12" type=cited from="[1998] FCA 699">trial judge required to choose</citphrase>
<citphrase id="cp2.13" type=cited from="[1998] FCA 699">advantage of trial judge in assessing witnesses</citphrase>
<citphrase id="cp2.14" type=cited from="[1998] FCA 699">question of fact</citphrase>
<citphrase id="cp2.15" type=cited from="[1998] FCA 699">no error shown. negligence</citphrase>
<citphrase id="cp2.16" type=cited from="[1998] FCA 699">medical negligence</citphrase>
<citphrase id="cp2.17" type=cited from="[1998] FCA 699">asthmatic child suffers brain damage after use of phenobarbitone prescribed by locum to combat effects of prior use of suppository</citphrase>
<citphrase id="cp2.18" type=cited from="[1998] FCA 699">whether phenobarbitone caused damage</citphrase>
<citphrase id="cp2.19" type=cited from="[1998] FCA 699">question of fact</citphrase>
<citphrase id="cp2.20" type=cited from="[1998] FCA 699">no error shown. negligence</citphrase>
<citphrase id="cp2.21" type=cited from="[1998] FCA 699">manufacturer's liability</citphrase>
<citphrase id="cp2.22" type=cited from="[1998] FCA 699">drug contained in suppository</citphrase>
<citphrase id="cp2.23" type=cited from="[1998] FCA 699">lack of warning as to possible consequences on packaging</citphrase>
<citphrase id="cp2.24" type=cited from="[1998] FCA 699">doctor prescribing would not have read packaging anyway</citphrase>
<citphrase id="cp2.25" type=cited from="[1998] FCA 699">causation not established</citphrase>
<citphrase id="cp2.26" type=cited from="[1998] FCA 699">question of fact</citphrase>
<citphrase id="cp2.27" type=cited from="[1998] FCA 699">no error shown. damages</citphrase>
<citphrase id="cp2.28" type=cited from="[1998] FCA 699">various heads</citphrase>
<citphrase id="cp2.29" type=cited from="[1998] FCA 699">questions of fact</citphrase>
<citphrase id="cp2.30" type=cited from="[1998] FCA 699">interest on past component of griffiths v kerkemeyer award to await decision of full court in another pending appeal</citphrase>
<citphrase id="cp2.31" type=cited from="[1998] FCA 699">otherwise no error shown. appeal</citphrase>
<citphrase id="cp2.32" type=cited from="[1998] FCA 699">appeal on questions of fact</citphrase>
<citphrase id="cp2.33" type=cited from="[1998] FCA 699">expert evidence</citphrase>
<citphrase id="cp2.34" type=cited from="[1998] FCA 699">conflict between opinions of experts</citphrase>
<citphrase id="cp2.35" type=cited from="[1998] FCA 699">advantage of trial judge</citphrase>
<citphrase id="cp2.36" type=cited from="[1998] FCA 699">principles applicable.</citphrase>
</citphrases>
<citances>
</citances>
<legistitles>
<title id="l0">DESIGNS ACT 2003 </title>
<title id="l1">DESIGNS ACT 2003 - SECT 50 Revocation of registration on surrender</title>
<title id="l2">EVIDENCE ACT 1995 </title>
<title id="l3">EVIDENCE ACT 1995 - SECT 131 Exclusion of evidence of settlement negotiations</title>
<title id="l4">FEDERAL COURT RULES </title>
</legistitles>
</case>